Psychiatry across the lifespan: From early risk to advanced age

Abstract

Get full access to this article

View all access options for this article.

References

Cheung

McKay R

Wand

APF (2025) Time for psychiatry of the advanced age. Australian and New Zealand Journal of Psychiatry 59: 855–858.

De Oliveira

Costa J

Gillies

Schaffer

, et al. (2025) New use of antidepressants among Australians up to 24 years of age remains high after the COVID-19 pandemic emergency era. Australian and New Zealand Journal of Psychiatry 59: 926–930.

Erlangsen

Høier

Nielsen

, et al. (2025) Use of suicide prevention helpline services by first-time, frequent, and daily callers: a national cohort study. Australian and New Zealand Journal of Psychiatry 59: 917–925.

Roberts

Clapperton

Spittal

(2025) Change points in Australian suicide rates: Trends from 2000 to 2022. Australian and New Zealand Journal of Psychiatry 59: 897–905.

Schlögelhofer

Lin

Markulev

, et al. (2025) Association between non-adherence to fish oil or placebo as a risk factor of transition to psychosis in ultra-high-risk individuals in the NEURAPRO study. Australian and New Zealand Journal of Psychiatry 59: 888–896.

Watkeys

O’Hare

Dean

, et al. (2025) Psychiatric diagnoses prior to the first onset of non-affective and affective psychoses. Australian and New Zealand Journal of Psychiatry 59: 859–862.

Wilson

Dobson

Wallis

, et al. (2025) Use of mental health treatment plans, psychological treatment services and antidepressants in young Australian women – A cohort study. Australian and New Zealand Journal of Psychiatry 59: 906–916.